Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 20.68
+0.14 (0.68%)
Jul 30, 2025, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 7.00 billion as of July 30, 2025. Its market cap has increased by 4.56% in one year.
Market Cap
7.00B
Enterprise Value
6.87B
Revenue
783.21M
Ranking
n/a
PE Ratio
143.02
Stock Price
20.68
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 7.00B, an increase of 4,502.97%. That is a compound annual growth rate of 64.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 6.95B | -15.63% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | 1.06B | 169.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 129.73B |
| Pro Medicus | 33.52B |
| Cochlear | 20.46B |
| Sonic Healthcare | 13.87B |
| Ramsay Health Care | 8.87B |
| Ansell | 4.48B |
| Mesoblast | 3.22B |
| Regis Healthcare | 2.40B |